Gladstone Institutional Advisory LLC Novartis Ag Transaction History

Gladstone Institutional Advisory LLC

  • $2.1 Billion
  • Q4 2024

A detailed history of Gladstone Institutional Advisory LLC transactions in Novartis Ag stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 6,977 shares of NVS stock, worth $777,795. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,977
Previous 7,167 2.65%
Holding current value
$777,795
Previous $824,000 17.72%
% of portfolio
0.03%
Previous 0.04%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$96.78 - $117.18 $18,388 - $22,264
-190 Reduced 2.65%
6,977 $678,000
Q3 2024

Oct 28, 2024
SELL
$106.13 - $120.89 $11,143 - $12,693
-105 Reduced 1.44%
7,167 $824,000
Q2 2024

Aug 02, 2024
BUY
$92.57 - $107.37 $55,264 - $64,099
597 Added 8.94%
7,272 $774,000
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $115,753 - $131,791
-1,215 Reduced 15.4%
6,675 $645,000
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $19,561 - $21,526
-212 Reduced 2.62%
7,890 $796,000
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $6,157 - $6,833
-65 Reduced 0.8%
8,102 $825,000
Q2 2023

Aug 10, 2023
SELL
$92.52 - $104.91 $5,921 - $6,714
-64 Reduced 0.78%
8,167 $824,000
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $9,523 - $11,044
119 Added 1.47%
8,231 $757,000
Q4 2022

Feb 01, 2023
BUY
$75.55 - $92.52 $6,723 - $8,234
89 Added 1.11%
8,112 $735,000
Q3 2022

Jan 27, 2023
BUY
$74.61 - $87.26 $4,998 - $5,846
67 Added 0.84%
8,023 $610,000
Q3 2022

Oct 20, 2022
BUY
$74.61 - $87.26 $4,998 - $5,846
67 Added 0.84%
8,023 $610,000
Q2 2022

Jan 27, 2023
SELL
$80.52 - $93.75 $104,192 - $121,312
-1,294 Reduced 13.99%
7,956 $673,000
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $104,192 - $121,312
-1,294 Reduced 13.99%
7,956 $673,000
Q1 2022

Jan 27, 2023
SELL
$80.11 - $90.62 $178,164 - $201,538
-2,224 Reduced 19.38%
9,250 $812,000
Q1 2022

May 04, 2022
SELL
$80.11 - $90.62 $178,164 - $201,538
-2,224 Reduced 19.38%
9,250 $812,000
Q4 2021

Jan 27, 2023
SELL
$79.7 - $88.13 $246,512 - $272,586
-3,093 Reduced 21.23%
11,474 $1 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $246,512 - $272,586
-3,093 Reduced 21.23%
11,474 $1 Million
Q3 2021

Jan 27, 2023
BUY
$81.78 - $95.14 $528,135 - $614,414
6,458 Added 79.64%
14,567 $1.19 Million
Q3 2021

Nov 15, 2021
BUY
$81.78 - $95.14 $528,135 - $614,414
6,458 Added 79.64%
14,567 $1.19 Million
Q2 2021

Jan 27, 2023
BUY
$85.24 - $94.15 $316,496 - $349,578
3,713 Added 84.46%
8,109 $740,000
Q2 2021

Aug 13, 2021
BUY
$85.24 - $94.15 $316,496 - $349,578
3,713 Added 84.46%
8,109 $740,000
Q1 2021

Jan 27, 2023
BUY
$83.5 - $98.47 $46,008 - $54,256
551 Added 14.33%
4,396 $376,000
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $46,008 - $54,256
551 Added 14.33%
4,396 $376,000
Q4 2020

Jan 27, 2023
SELL
$78.07 - $94.43 $35,131 - $42,493
-450 Reduced 10.48%
3,845 $363,000
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $35,131 - $42,493
-450 Reduced 10.48%
3,845 $363,000
Q3 2020

Jan 27, 2023
SELL
$82.14 - $91.0 $306,217 - $339,248
-3,728 Reduced 46.47%
4,295 $374,000
Q3 2020

Nov 16, 2020
BUY
$82.14 - $91.0 $17,988 - $19,929
219 Added 5.37%
4,295 $374,000
Q2 2020

Aug 17, 2020
SELL
$80.93 - $91.1 $36,661 - $41,268
-453 Reduced 10.0%
4,076 $356,000
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $35,193 - $49,306
-498 Reduced 9.91%
4,529 $374,000
Q4 2019

Feb 12, 2020
SELL
$84.35 - $95.37 $59,129 - $66,854
-701 Reduced 12.24%
5,027 $476,000
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $279,288 - $307,758
3,265 Added 132.56%
5,728 $498,000
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $185,710 - $228,566
2,463 New
2,463 $225,000

Others Institutions Holding NVS

# of Institutions
1,486
Shares Held
131M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $240B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Gladstone Institutional Advisory LLC Portfolio

Follow Gladstone Institutional Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email